Literature DB >> 17433531

Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship.

Abraham Morgentaler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17433531     DOI： 10.1016/j.eururo.2007.04.005

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  10 in total

1.  Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy.

Authors:  Eduard García-Cruz; Jorge Huguet; Marta Piqueras; Meritxell Pérez Márquez; Lluís Peri; Laura Izquierdo; Agustín Franco; Ricardo Alvarez-Vijande; María José Ribal; Antonio Alcaraz
Journal:  World J Urol       Date:  2011-08-11       Impact factor: 4.226

Review 2.  Differing levels of testosterone and the prostate: a physiological interplay.

Authors:  S Larry Goldenberg; Anthony Koupparis; Michael E Robinson
Journal:  Nat Rev Urol       Date:  2011-05-31       Impact factor: 14.432

3.  Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml.

Authors:  Jin Mo Koo; Bong Suk Shim
Journal:  Korean J Urol       Date:  2010-12-21

Review 4.  When and when not to use testosterone for palliation in cancer care.

Authors:  Rony Dev; Eduardo Bruera; Egidio Del Fabbro
Journal:  Curr Oncol Rep       Date:  2014-04       Impact factor: 5.075

5.  Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.

Authors:  Göksel Bayar; Hakan Şirin; Mustafa Aydın; Ayşim Özağarı; Orhan Tanrıverdi; Mustafa Kadıhasanoğlu; Muammer Kendirci
Journal:  Turk J Urol       Date:  2017-08-01

Review 6.  [Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].

Authors:  L Rinnab; K Gust; R E Hautmann; R Küfer
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

7.  Prostate size and adverse pathologic features in men undergoing radical prostatectomy.

Authors:  Sung Kyu Hong; Bing Ying Poon; Daniel D Sjoberg; Peter T Scardino; James A Eastham
Journal:  Urology       Date:  2014-07       Impact factor: 2.649

8.  Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance.

Authors:  A F Kotb; S Tanguay; M A Luz; W Kassouf; A G Aprikian
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-10-12       Impact factor: 5.554

9.  Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result.

Authors:  Alexandros Fiamegos; John Varkarakis; Michael Kontraros; Andreas Karagiannis; Michael Chrisofos; Dimitrios Barbalias; Charalampos Deliveliotis
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

Review 10.  Testosterone deficiency: a historical perspective.

Authors:  Eberhard Nieschlag; Susan Nieschlag
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.